VIRAL-ASSOCIATED HEMOPHAGOCYTIC SYNDROME
Clinical trials for VIRAL-ASSOCIATED HEMOPHAGOCYTIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new VIRAL-ASSOCIATED HEMOPHAGOCYTIC SYNDROME trials appear
Sign up with your email to follow new studies for VIRAL-ASSOCIATED HEMOPHAGOCYTIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered t cells with a kill switch aim to make stem cell transplants safer
Disease control OngoingThis study tests a new approach for people receiving a stem cell transplant from a partially matched family donor. The donor's immune cells (T cells) are modified in the lab to include a 'suicide gene' that can be activated by a drug if the cells attack the patient's body, causin…
Matched conditions: VIRAL-ASSOCIATED HEMOPHAGOCYTIC SYNDROME
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Suicide Gene-Equipped t cells aim to make stem cell transplants safer
Disease control OngoingThis trial tests whether specially modified T cells from a partially matched donor can help patients recover their immune system faster after a stem cell transplant. The T cells are engineered with a 'suicide gene' that allows doctors to destroy them if they cause graft-versus-ho…
Matched conditions: VIRAL-ASSOCIATED HEMOPHAGOCYTIC SYNDROME
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC